These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 904574)

  • 1. [Oral treatment of arrhythmias in the WPW and LGL-syndrome using Amidonal].
    Brisse B; Bender F
    Med Monatsschr; 1977 Sep; 31(9):412-4. PubMed ID: 904574
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of cardiac arrhythmias with N-propyl-ajmalinium-hydrogentartrat (Neo-Gilurytmal (author's transl)].
    So CS; Oversohl K; Seidl KF
    Med Klin; 1974 May; 69(18):814-7. PubMed ID: 4134646
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of aprindine on ventricular arrhthmias].
    Domínguez JF; Martín Sánchez JC; Ciscar A; Hidalgo M; Petit Guinovart M; Ballesta Barcons F
    Rev Esp Cardiol; 1975; 38(2):145-52. PubMed ID: 49071
    [No Abstract]   [Full Text] [Related]  

  • 4. Aprindine (AC 1802), a new anti-arrhythmic drug.
    Kesteloot H; Van Mieghem W; De Geest H
    Acta Cardiol; 1973; 28(2):145-65. PubMed ID: 4121909
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmacology and clinical evaluation of aprindine a new antiarrhythmic agent.
    Fasola AF; Carmichael R
    Acta Cardiol; 1974; Suppl 18():317-33. PubMed ID: 4138741
    [No Abstract]   [Full Text] [Related]  

  • 6. [Circulatory arrest after combined intravenous drugs for the treatment of orthodromic circular tachycardia of Wolff-Parkinson-White syndrome].
    Gómez-Barrado JJ; García-Rubira JC; Turégano Albarrán S; Pavón García M; Hidalgo Urbano R; Montes Ramírez JM; Cruz Fernández JM
    Rev Esp Cardiol; 1997 Sep; 50(9):662-6. PubMed ID: 9380937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Unfavorable course of the ventricular preexcitation syndrome. Apropos of 3 cases].
    Poveda Sierra J; Pajarón A; Medrano GA
    Arch Inst Cardiol Mex; 1973; 43(6):837-47. PubMed ID: 4773501
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience with propafenone in paroxysmal supraventricular reciprocating tachycardias].
    Furlanello F; Vergara G; Dal Forno P; Disertori M; Inama G
    G Ital Cardiol; 1984 May; 14(5):379-80. PubMed ID: 6468821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of refractory arrhythmias by aprindine in patients with the Wolff-Parkinson-White syndrome.
    Reid PR; Greene HL; Varghese PJ
    Br Heart J; 1977 Dec; 39(12):1353-60. PubMed ID: 603737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride.
    Rosenbaum MB; Chiale PA; Ryba D; Elizari MV
    Am J Cardiol; 1974 Aug; 34(2):215-23. PubMed ID: 4843156
    [No Abstract]   [Full Text] [Related]  

  • 11. A quick guide to converting rapid rhythms. When seconds count, use this chart to guide treatment choices.
    Sandrock J
    Nursing; 1997 Mar; 27(3):32ss. PubMed ID: 9171625
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of aprindine on the induction and termination of supraventricular tachycardia in patients with accessory pathway syndrome].
    Kubota K; Ikeda T; Takata S; Murakami T; Nakamura S; Fujiki A; Higashino A; Hattori N
    Kokyu To Junkan; 1985 Jul; 33(7):913-9. PubMed ID: 4059681
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical contribution in the treatment of paroxysmal tachycardia].
    Tassone F
    Minerva Med; 1974 Sep; 65(60):3140-6. PubMed ID: 4153900
    [No Abstract]   [Full Text] [Related]  

  • 14. [Electrophysiologic effects of intravenous and oral encainide in patients with Wolff-Parkinson-White syndrome and paroxysmal atrial fibrillation].
    Chimienti M; Moizi M; Salerno JA; Klersy C; Marangoni E; Previtali M; Montemartini C; Bobba P
    Cardiologia; 1986 Feb; 31(2):155-61. PubMed ID: 3098424
    [No Abstract]   [Full Text] [Related]  

  • 15. The clinical use of oral flecainide.
    Slama R; LeClercq JF
    Drugs; 1985; 29 Suppl 4():28-9. PubMed ID: 4006778
    [No Abstract]   [Full Text] [Related]  

  • 16. Aprindine for treatment of supraventricular tachycardias. With particular application to Wolff-Parkinson-White syndrome.
    Zipes DP; Gaum WE; Foster PR; Rosen KM; Wu D; Amat-Y-Leon F; Noble RJ
    Am J Cardiol; 1977 Oct; 40(4):586-96. PubMed ID: 910722
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intravenous verapamil for paroxysmal supraventricular tachycardia in Wolff-Parkinson-White syndrome].
    Nissimov R
    Harefuah; 1982 Mar; 102(6):234-7. PubMed ID: 7160717
    [No Abstract]   [Full Text] [Related]  

  • 18. Aprindine in the treatment of the idiopathic QT interval prolongation syndrome.
    Alves LE; Rose EP; Mueller HS
    Chest; 1982 Feb; 81(2):253-5. PubMed ID: 7056094
    [No Abstract]   [Full Text] [Related]  

  • 19. [The anti-arrhythmia effect and hemodynamic effects of Bonnecor in intravenous administration].
    Volkmann H; Kühnert H; Dannberg G; Küch N; Büttner A
    Z Gesamte Inn Med; 1989 Dec; 44(23):707-11. PubMed ID: 2629366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute therapy of tachycardic arrhythmias. 2: Supraventricular tachycardia--atrioventricular tachycardia (WPW syndrome)].
    Gonska BD; Rab J
    Fortschr Med; 1995 Mar; 113(7):87-9. PubMed ID: 7750890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.